ClinicalTrials.Veeva

Menu

A Predictive Model Based on Narrow Band Imaging for Early Gastric Cancerous Lesions

S

Shanghai Jiao Tong University School of Medicine

Status

Not yet enrolling

Conditions

Early Gastric Cancer

Treatments

Device: NBI

Study type

Interventional

Funder types

Other

Identifiers

NCT02968069
2016-138k

Details and patient eligibility

About

Without high diagnostic efficacy of endoscopic forceps biopsy (EFB) and with low diagnostic efficacy of narrow band imaging (NBI) in novice endoscopists and endoscopists of community hospitals in China, it is urgent to improve diagnostic efficacy for gastric cancerous lesions.The investigators will conduct a study to develop and validate a diagnostic model based on NBI for early gastric cancerous lesions under endoscopic observation.

Full description

Endoscopic forceps biopsy (EFB) is considered the gold standard and most commonly used for histological diagnosis of gastric epithelial neoplasia before proper management.Many studies have shown that there exist considerable discrepancies between EFB and subsequently resected specimens with discrepancy rate of 27.1-44.5%. On the other hand, with low diagnostic efficacy of narrow band imaging (NBI) in novice endoscopists and endoscopists of community hospitals in China, not higher diagnostic accuracy of gastric cancerous lesions could be observed. Here, the investigators will conduct a study to develop and validate a diagnostic model based on narrow band imaging for early gastric cancerous lesions under endoscopic observation, trying to improve overall diagnostic efficacy for gastric cancerous lesions.

Enrollment

300 estimated patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Suspected of having a cancerous lesions
  • The age of patients is from 40-80 years
  • Patients must undergo esophagogastroduodenoscopy

Exclusion criteria

  • Clinical diagnosis of advanced gastric cancer
  • Acute upper gastrointestinal bleeding
  • Severe systemic diseases
  • Refuse to attend the study

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

300 participants in 1 patient group

Suspected gastric cancerous lesions
Experimental group
Description:
Magnifying endoscopy with NBI would be conducted for every patient included in our study
Treatment:
Device: NBI

Trial contacts and locations

0

Loading...

Central trial contact

Xiaobo Li, MD.Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems